Aditya Birla
Aditya Birla Money Limited
  • SENSEX 36737.69408.68 1.12%
  • NIFTY 10813.45107.70 1.01%
Get Quotes
Last Update : 09 Jul
Sun Pharmaceuticals Industries Ltd
(Public, BOM:500038)
Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln
Sector: Pharmaceuticals
Price
Rs. 482.05
-0.4%
  • Technical Analysis
  • Benchmark
BSE NSE
  • 1 Day
  • 5 Day
  • 1 Mon
  • 3 Mon
  • 6 Mon
  • 1 Yr
SUN PHARMA. Industry
Average
Market Cap. 116,127.81 9,484.51
Beta 0.55 0.48
EPS (TTM) 13.38 16.57
P/E Ratio (TTM) 36.17 23.94
Dividend Yield (TTM) 0.83 0.50
Institutions 19.56 5.24
Book Value 101.68 
P/B 4.76 
Div(%) 275.00  -
Face Value 1.00 
Related News
[07-Jul-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[06-Jul-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[03-Jul-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[02-Jul-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[01-Jul-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[30-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[29-Jun-2020] Sun Pharmaceutical Industries receives Japan MHLW approval for ILUMYA
[29-Jun-2020] Sun Pharma climbs after unit gets Japan's nod for ILUMYA
[29-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[29-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[26-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[24-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[24-Jun-2020] Sun Pharmaceuticals Industries Ltd - Intimation Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
[23-Jun-2020] Sun Pharmaceuticals Industries Ltd rises for third consecutive session
[22-Jun-2020] Sun Pharmaceuticals Industries Ltd - Closure of Trading Window
[15-Jun-2020] Sun Pharma and Hikma enter into exclusive licensing agreement for ILUMYA™
[15-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[13-Jun-2020] Sun Pharma presents clinical insights into specialty medicines ODOMZO and LEVULAN® KERASTICK®
[13-Jun-2020] Sun Pharma presents long term insights into clinical use of ILUMYA®
[13-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[13-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[11-Jun-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[09-Jun-2020] Sun Pharma gains after promoter releases pledge
[09-Jun-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[09-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[08-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[05-Jun-2020] Sun Pharmaceutical Industries commences Phase II clinical trail on a plant derived drug against COVID-19
[05-Jun-2020] Sun Pharma gains on testing plant-based drug as potential Covid-19 treatment
[05-Jun-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[05-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[04-Jun-2020] Sun Pharmaceuticals Industries Ltd rises for third consecutive session
[04-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[03-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[02-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Disclosure under SEBI Takeover Regulations
[01-Jun-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[29-May-2020] Sun Pharma receives DCGI approval to initiate clinical trail with Nafamostat Mesilate in Covid-19 patients
[29-May-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[29-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[28-May-2020] SPARC and Sun Pharma enter into licensing agreement for a potential dermatology product
[28-May-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[28-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[27-May-2020] Sun Pharmaceuticals Industries consolidated net profit declines 37.12% in the March 2020 quarter
[27-May-2020] Sun Pharma Q4 PAT declines 37% to 399 cr
[27-May-2020] Board of Sun Pharmaceuticals Industries recommends final dividend
[27-May-2020] Sun Pharmaceuticals Industries Ltd - Approval Of Audited Financial Statements For The Quarter And Year Ended March 31, 2020 And Recommendation Of Payment Of Final Dividend For The Financial Year Ended March 31, 2020
[27-May-2020] Sun Pharmaceuticals Industries Ltd - Approval Of Audited Financial Statements For The Quarter And Year Ended March 31, 2020 And Recommendation Of Payment Of Final Dividend For The Financial Year Ended March 31, 2020
[27-May-2020] Sun Pharmaceuticals Industries Ltd - Corporate Action-Board approves Dividend
[27-May-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[27-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[26-May-2020] Sun Pharmaceuticals Industries Ltd gains for fifth session
[26-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[23-May-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[22-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[21-May-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[21-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[20-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[19-May-2020] Sun Pharmaceuticals Industries to hold board meeting
[19-May-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[19-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[18-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[15-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[14-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[13-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[12-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[11-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[08-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[07-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[06-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[05-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[04-May-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[04-May-2020] Sun Pharmaceuticals Industries Ltd - Statement Of Investor Complaints For The Quarter Ended March 2020
[04-May-2020] Sun Pharmaceuticals Industries Ltd - Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
[04-May-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[30-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[29-Apr-2020] Sun Pharmaceuticals Industries Ltd - Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
[29-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[28-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[27-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
[24-Apr-2020] Sun Pharmaceuticals Industries Ltd spurts 3.63%
[24-Apr-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
[24-Apr-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
[24-Apr-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
[24-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[23-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[22-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[22-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[22-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[22-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[21-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[20-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[17-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[16-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[15-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[15-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[13-Apr-2020] Sun Pharmaceuticals Industries Ltd spurts 3.83%, gains for fifth straight session
[13-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[09-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[08-Apr-2020] Sun Pharmaceuticals Industries Ltd gains for third consecutive session
[08-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[07-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[03-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[03-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[01-Apr-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[01-Apr-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[31-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[30-Mar-2020] USFDA classified Sun Pharma's Halol facility as Official Action Indicated
[30-Mar-2020] Sun Pharma's Halol facility gets OAI status from USFDA
[30-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[29-Mar-2020] Sun Pharmaceuticals Industries Ltd - Update On Halol Facility
[29-Mar-2020] Sun Pharmaceuticals Industries Ltd - Additional Details For OAI Classification For Halol Facility
[27-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Daily Buy-Back of equity shares
[25-Mar-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[25-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Trading Window
[24-Mar-2020] Sun Pharmaceuticals Industries Ltd - Closure of Trading Window
[20-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Public Announcement - Buyback of Shares
[19-Mar-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Public Announcement-Buyback of Shares
[17-Mar-2020] Sun Pharma announces Rs 1,700 cr share buyback offer
[17-Mar-2020] Board of Sun Pharmaceutical Industries approves buyback of shares up to Rs 1700 cr
[17-Mar-2020] Sun Pharmaceuticals Industries Ltd - Outcome Of Board Meeting Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended,('Listing Regulations').
[17-Mar-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Meeting Updates
[17-Mar-2020] Sun Pharmaceuticals Industries Ltd - Board approves Buy-back of equity shares
[17-Mar-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Outcome of Board Meeting
[16-Mar-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[13-Mar-2020] Sun Pharmaceuticals Industries to hold board meeting
[12-Mar-2020] Sun Pharmaceuticals Industries Ltd extends losing spree
[12-Mar-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[07-Mar-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
[28-Feb-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[28-Feb-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
[26-Feb-2020] Sun Pharmaceutical Industries launches Riomet ER™ in US
[26-Feb-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[26-Feb-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[20-Feb-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[18-Feb-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
[14-Feb-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[11-Feb-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
[07-Feb-2020] Sun Pharma Q3 PAT slides 26% to Rs 913.52 crore
[07-Feb-2020] Sun Pharmaceutical Industries fixes record date for interim dividend
[07-Feb-2020] Sun Pharmaceuticals Industries Ltd - Fixes Record Date for Interim Dividend
[06-Feb-2020] Sun Pharmaceuticals Industries consolidated net profit declines 26.44% in the December 2019 quarter
[06-Feb-2020] Sun Pharma Q3 PAT slides 26% to Rs 913.52 cr
[06-Feb-2020] Board of Sun Pharmaceutical Industries recommends interim dividend
[06-Feb-2020] Sun Pharmaceuticals Industries fixes record date for interim dividend
[06-Feb-2020] Sun Pharmaceuticals Industries Ltd - Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2019 And Declaration Of An Interim Dividend
[06-Feb-2020] Sun Pharmaceuticals Industries Ltd - Corporate Action-Board approves Dividend
[06-Feb-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[06-Feb-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Dividend
[05-Feb-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[04-Feb-2020] Sun Pharma rises on bargain hunting; shrugs weak Q3 show by Taro
[04-Feb-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[03-Feb-2020] Sun Pharmaceuticals Industries Ltd drops for fifth straight session
[03-Feb-2020] Sun Pharmaceuticals Industries Ltd - Corporate Action-Board to consider Dividend
[24-Jan-2020] Sun Pharmaceuticals Industries Ltd - Loss of Share Certificate / Issue of Duplicate Share Certificate
[20-Jan-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[20-Jan-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[17-Jan-2020] Sun Pharmaceuticals Industries announces board meeting date
[17-Jan-2020] Sun Pharmaceuticals Industries Ltd - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
[16-Jan-2020] Sun Pharmaceuticals Industries Ltd extends winning spree
[16-Jan-2020] Sun Pharmaceuticals Industries Ltd - Statement Of Investor Complaints For The Quarter Ended December 2019
[16-Jan-2020] Sun Pharmaceuticals Industries Ltd - Board Meeting Intimation for Notice Of Board Meeting For Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2019
[15-Jan-2020] Sun Pharma enters into licensing and supply agreement with Rockwell Medical
[15-Jan-2020] Sun Pharma gains on partnership with Michigan-based Rockwell Medical
[15-Jan-2020] Sun Pharmaceuticals Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release
[15-Jan-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
[15-Jan-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release
[13-Jan-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
[13-Jan-2020] Sun Pharmaceuticals Industries Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
[13-Jan-2020] Sun Pharmaceuticals Industries Ltd - Sun Pharmaceutical Industries Limited - Updates
  • CONTACT US

For Broking services call 1800-270-7000 (Toll free) -
(9 am-11:30pm- Mon-Fri &
9am-9pm- Sat & Sun)
For Call N Trade
Call 1800 108 9999 & Dial 1
(9am-11:30pm)

Request a Call Back

Broking & Commodity:
care.stocksandsecurities@
adityabirlacapital.com
Depository Operations:
dpcare.stocksandsecurities@
adityabirlacapital.com

Get to a branch closest to you

 ABML Branches
Locate Us

To reach us for any of our services, SMS the below short codes to 567679

  1. Broking/Distribution SMS: ABM to 567679
  2. Franchisee Partner: ABM to 567679
  3. Portfolio Management Services: ABMCS 567679

Share with us your valuable
feedback

Click Here

ATTENTION INVESTORS :

Securities Broking is through Aditya Birla Money Limited: SEBI Registration No. NSE/BSE/MCX/NCDEX:INZ000172636 ; NSDL /CDSL: IN-DP-17-2015. PMS - INP 000003757, Research Analyst –INH000002145, Investment Adviser - INA000009214. Central Insurance Repository Limited: IRDA/IR2/2014/312. Investments in securities market are subject to market risks, read all the related documents carefully before investing. Please read the risk disclosure document, rights and obligations, guidance note, Do’s and Don’ts and policies and procedure carefully before making any investment decision. Brokerage will not exceed the SEBI prescribed limit. Margins as prescribed by Exchange / SEBI will be applicable.
Corporate Office: Sai Sagar, 2nd & 3rd Floor, Plot No.M-7, Thiru-Vi-Ka (SIDCO) Industrial Estate, Guindy, Chennai 600032. Regd. office: Indian Rayon Compound, Veraval, Gujarat - 362 266 | E-mail: care.stocksandsecurities@adityabirlacapital.com | CIN L65993GJ1995PLC064810 | Tel: +91-44-49490000 / 4949 0200 | Website: stocksandsecurities.adityabirlacapital.com